M. J. Van der Veen

Publication List Details

Period

2000 - 2000

Number

9

Co-Authors

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial (2000)

Van Jaarsveld, C.H.M., Jacobs, J.W.G., Van Der Veen, M.J., Blaauw, A.A.M., Kruize, A.A., Hofman, D.M., ...

Objectives-To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time...

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial (2000)

Van Jaarsveld, C.H.M., Jacobs, J.W.G., Van Der Veen, M.J., Blaauw, A.A.M., Kruize, A.A., Hofman, D.M., ...

Objectives-To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time...

Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.

Cornelissen, J J, Bakker, L J, Van Der Veen, M J, Rozenberg-Arska, M, Bijlsma, J W

Low dose methotrexate is used increasingly often in the treatment of rheumatoid arthritis. Severe complications due to toxicity of the lung or bone marrow occur infrequently. This report describes a...

Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.

Van Der Veen, M J, Van Der Heide, A, Kruize, A A, Bijlsma, J W

OBJECTIVE--To investigate prospectively the frequency and type of infections and the use of antibiotics among patients with rheumatoid arthritis (RA) on methotrexate (MTX) and patients with RA...

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

Van Der Veen, M J, Dinant, H J, Van Booma-Frankfort, C, Van Albada-Kuipers, G A, Bijlsma, J W

OBJECTIVE: To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). METHODS: We carried out a randomised...

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial

Van Jaarsveld, C H M, Jacobs, J, Van Der Veen, M J, Blaauw, A, Kruize, A, Hofman, D, ...

OBJECTIVES—To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time...

Determinants of direct costs in Dutch rheumatoid arthritis patients

Verstappen, S, Verkleij, H, Bijlsma, J, Buskens, E, Kruize, A, Heurkens, A, ...

Objectives: To estimate annual direct costs in four distinct disease duration groups (0 to ⩽2, 2 to ⩽6, 6 to ⩽10, and >10 years) of patients with rheumatoid arthritis (RA), to determine...